CAS: 340021-17-2 - Tonapofylline
Formula:C22H32N4O4
InChI:InChI=1S/C22H32N4O4/c1-3-13-25-17-16(18(29)26(14-4-2)20(25)30)23-19(24-17)22-10-7-21(8-11-22,9-12-22)6-5-15(27)28/h3-14H2,1-2H3,(H,23,24)(H,27,28)
InChI key:InChIKey=ZWTVVWUOTJRXKM-UHFFFAOYSA-N
SMILES:O=C(O)CCC12CCC(C3=NC4=C(N3)C(=O)N(C(=O)N4CCC)CCC)(CC1)CC2
- Synonyms:
- Tonapofylline
- 4-(2,3,6,7-Tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)bicyclo[2.2.2]octane-1-propanoic acid
- BG 9928
- Bicyclo[2.2.2]octane-1-propanoic acid, 4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Tonapofylline REF: 3D-QNA02117CAS: 340021-17-2 | Min. 95% | To inquire | Tue 18 Feb 25 |
 | Tonapofylline REF: TM-T17117CAS: 340021-17-2 | 99.52% | 43.00 €~551.00 € | Mon 07 Apr 25 |
Tonapofylline
CAS:340021-17-2
Tonapofylline is a pharmaceutical preparation that is used to treat glomerular filtration rate problems and …
Formula:
C22H32N4O4
Purity:
Min. 95%
Molecular weight:
416.5 g/mol
Ref: 3D-QNA02117
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Tonapofylline
CAS:340021-17-2
Tonapofylline, orally active, selectively blocks A1 adenosine receptor (Ki: 7.4 nM), used in heart failure …
Formula:
C22H32N4O4
Purity:
99.52%
Color and Shape:
Solid
Molecular weight:
416.51
Ref: TM-T17117
| 1mg | 43.00 € | ||
| 5mg | 95.00 € | ||
| 10mg | 138.00 € | ||
| 25mg | 267.00 € | ||
| 50mg | 387.00 € | ||
| 100mg | 551.00 € | ||
| 1mL*10mM (DMSO) | 95.00 € |
Estimated delivery in United States, on Monday 7 Apr 2025
